Keywords: Ranbaxy, Sumatriptan, migraine

US FDA approves Ranbaxy’s generic sumatriptan

Article | 11 August 2009

Print This

The US subsidiary of Indian drugmaker Ranbaxy has received final approval from the U. Food and Drug Administration to manufacture ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in